Hjem › Blærekreft › District of Columbia › Washington
Kliniske studier for Blærekreft i Washington, DC
26 studier for Blærekreft søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
RekruttererFase 3
- Sibley Memorial Hospital ( Site 0849), Washington D.C.
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Evaluation for NCI Surgery Branch Clinical Research Protocols
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
- Sibley Memorial Hospital, Washington D.C.
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
- Sibley Memorial Hospital Pharmacy Department, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- MedStar Washington Hospital Center, Washington D.C.
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- National Institutes of Health, Bethesda · 7 mi unna
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- The George Washington Medical Faculty Associates, Washington D.C.
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruttererFase 2/3
- Sibley Memorial Hospital, Washington D.C.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruttererFase 2
- Medstar Washington Hospital Center, Washington D.C.
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
RekruttererFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Cancer Support Community Research & Training Institute, Washington D.C.
Renal Retention in High Grade Upper Tract Urothelial Cancer
RekruttererFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Blue Light Cystoscopy With Cysview® Registry
RekruttererObservasjonsstudie
- Sibley Memorial Hospital, Washington D.C.
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Rekrutterer
- Sibley Memorial Hospital, Washington D.C.
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
RekruttererFase 3
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi unna
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi unna
Gender Related Coping and Survivorship for Genitourinary Cancers
RekruttererObservasjonsstudie
- Sibley Memorial Hospital, Washington D.C.
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- Philadelphia, PA22 studier
- St. Louis, MO22 studier
- Edison, NJ21 studier
- Chicago, IL21 studier
- Seattle, WA21 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Akut myelogen leukemi24 studier
- Lymfom23 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.